New findings suggest semaglutide's benefits may extend well beyond diabetes and weight loss and into airway disease and mood disorders.
|Articles|August 7, 2008
Now there's an echinocandin antifungal to treat kids
Cancidas, previously approved for use in adults, can now be applied also to pediatric patients aged three months to 17 years.
Advertisement
Merck's Cancidas (caspofungin acetate), previously approved for use in adults, can now be applied also to pediatric patients aged three months to 17 years. The Whitehouse Station, N.J., firm claims that the approval makes
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Related to this article
First approved for adults in 2022, the therapy is now cleared for children 12-18 with symptomatic obstructive hypertrophic cardiomyopathy.
With the inherent value medications provide in the greater health care system, Jennifer Hammons, PharmD, DrPH, argues that rural pharmacies deserve the proper recognition.
A claims analysis of 2031 patients aged 10 to 17 years found that nutrition counseling was infrequent and often began months after treatment started.
Community pharmacists offer accessible care, improve medication adherence, and build trust through education, vaccination support, and local health leadership.
Researchers compared vaccine coadministration with single-dose, sequential vaccination for the RSVPreF3 OA vaccine formulation in adults.
A study of women aged 50 to 69 years found that thrombotic risk varied by route of administration, estradiol dose, and duration of use.
Despite technology fostering a new generation of health care delivery, experts believe rural health solutions should be sought elsewhere.
Advertisement
Advertisement
Trending on Drug Topics
1
What Is HIV PrEP and Who Needs It Most?
2
Normal vs. Concerning COVID-19 Vaccine Reactions: A Pharmacist's Guide
3
Validating Fear Before Facts: A Framework for COVID-19 Hesitancy
4
Why Rural Pharmacies Are Essential Infrastructure in US Health Care
5